Sigma‐2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy

E-ISSN： 1098-1128|34|3|532-566

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.34, Iss.3, 2014-05, pp. : 532-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

MEDICINAL RESEARCH REVIEWS, Vol. 35, Iss. 4, 2015-07 ,pp. : 790-848

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer

Combinatorial Chemistry & High Throughput Screening, Vol. 11, Iss. 1, 2008-01 ,pp. : 62-69

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin Receptor‐Mediated Specific Delivery of Paclitaxel Prodrugs for Efficient Cancer Therapy

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 6, 2015-06 ,pp. : 2018-2028

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tritiation of delta opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity containing 2′, 6′dimethyltyrosine

By Kertész I. Tóth G. Balboni G. Guerrini R. Salvadori S.

Czechoslovak Journal of Physics, Vol. 49, Iss. 1, 1999-01 ,pp. : 887-892

Springer Publishing Company

Access to resources Recommend Favorite

Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands

ANGEWANDTE CHEMIE, Vol. 127, Iss. 5, 2015-01 ,pp. : 1571-1575

John Wiley & Sons Inc

Access to resources Recommend Favorite